4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000113
SVP & Chief Accounting Officer sold 240 shares at $419.00 ($100,560)
- SVP & Chief Accounting Officer gave up 225 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ambrose Kristen · SVP & Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-01 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −225 | $418.10 | $94,073 | 7,740 | D |
| 2024-04-02 | Sale : show line 2 in the form 10b5-1 | −240 | $419.00 | $100,560 | 7,500 | D |
| Open-market sales · 240 sh · avg $419.00 · $100,560 | ||||||
Loading xslF345X05/wk-form4_1712174533.xml…